Chadi’s guest Kashyap Patel, MD, president of the Community Oncology Alliance (COA), joins the show to give an update on the current initiatives and state of COA and community oncology as a whole. He chronicles his journey to becoming a medical oncologist at a small community center outside of Charlotte (SC) and how he became aware of the pain points of community oncology in the U.S. The conversation moved into the history and initial aim of COA to help community practices prepare to work with and have an identity when facing policymakers, how COA membership dues are put to use, the top five problems facing community oncology today, and why many community practices feel compelled to sell to large health systems. Dr. Patel also shares his vision as the president of COA and what he hopes to accomplish before his term ends.
N/A
Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous
Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those
Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease
